Travere Therapeutics, Inc.
TVTX
50 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | May 6 8:03 PM | ELIZABETH REED | Proposed Sale | 2,076 | $43.95 | $91.2K | — | View → |
| May 6, 2026 | May 6 8:02 PM | JULA INRIG | Proposed Sale | 311 | $43.95 | $13.7K | — | View → |
| May 6, 2026 | May 6 1:55 PM | Dube Eric M | Proposed Sale | 22,500 | $43.95 | $988.9K | — | View → |
| May 6, 2026 | May 6 1:37 PM | ROTE WILLIAM E. | Proposed Sale | 2,763 | $43.95 | $121.4K | — | View → |
| May 5, 2026 | May 5 11:48 PM | Christopher Cline | Proposed Sale | 2,181 | $46.65 | $101.7K | — | View → |
| May 5, 2026 | May 5 11:32 PM | Elizabeth E. Reed | Proposed Sale | 2,174 | $46.65 | $101.4K | — | View → |
| May 5, 2026 | May 5 11:31 PM | Jula Inrig | Proposed Sale | 2,174 | $46.65 | $101.4K | — | View → |
| May 5, 2026 | May 5 11:31 PM | Peter Heerma | Proposed Sale | 2,174 | $46.65 | $101.4K | — | View → |
| May 5, 2026 | May 5 8:53 PM | ROY BAYNES | Proposed Sale | 4,500 | $46.65 | $209.9K | — | View → |
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Sale | 9,750 | $44.22 | $431.1K | 37,500(D) | View → |
| May 4, 2026 | May 4 8:04 PM | ELIZABETH REED | Proposed Sale | 20,000 | $45.00 | $900.0K | — | View → |
| May 4, 2026 | May 4 8:04 PM | JEFFREY MECKLER | Proposed Sale | 8,000 | $45.00 | $360.0K | — | View → |
| May 4, 2026 | May 4 8:03 PM | JULA INRIG | Proposed Sale | 20,000 | $45.00 | $900.0K | — | View → |
| May 1, 2026 | May 1 8:15 PM | ROY BAYNES | Proposed Sale | 9,750 | $44.22 | $431.1K | — | View → |
| Apr 22, 2026 | Apr 23 8:05 PM | William E. RoteChief Research Officer | Sale | 9,100 | $39.09 | $355.7K | 113,987(D) | View → |
| Apr 22, 2026 | Apr 22 2:36 PM | ROTE WILLIAM E. | Proposed Sale | 9,100 | $39.09 | $355.7K | — | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Sale | 8,000 | $41.07 | $328.6K | 57,500(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Sale | 32,750 | $41.29 | $1.4M | 37,500(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Sale | 21,977 | $41.07 | $902.6K | 42,353(D) | View → |
| Apr 14, 2026 | Apr 16 1:49 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 7,215 | $41.93 | $302.5K | 138,608(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 30,000(D) | View → |
← Previous
Page 3 of 3